Cell line will be used in vaccine production.

Crucell and Pfizer Animal Health signed  a research license agreement for PER.C6®. The deal allows Pfizer Animal Health to use the cell technology in the production of a undisclosed veterinary vaccine.

Pfizer Animal Health has an option to convert the research license into a commercial agreement.

This site uses Akismet to reduce spam. Learn how your comment data is processed.